BrainStorm gets US FDA nod to begin phase 3b trial of NurOwn to treat amyotrophic lateral sclerosis

Join Pharma | Login

	Editorial


	THE OTC POLICY
	Wednesday, May 21, 2025
	The Tamil Nadu Pharmaceutical Traders Association has recently urged the Drugs Technical Advisory Board (DTAB) of the Union Health Ministry not to support the proposal for allowing sale of over-the-counter (OTC) medicines in non-pharmaceutical shops
	Past Editorial...

TODAY'S NEWS


18:00 [IST]	BrainStorm gets US FDA nod to begin phase 3b trial of NurOwn to treat amyotrophic lateral sclerosis
17:30 [IST]	Thangam Robotic Institute, Namakkal becomes hub for robotic-assisted thoracic surgeries
17:10 [IST]	Senores Pharma acquires ANDA for enalapril maleate tablets 2.5mg, 5mg, 10mg and 20mg from Wockhardt
17:00 [IST]	ITM Isotope Technologies & Radiopharm Theranostics ink supply agreement for n.c.a. Lutetium-177
16:45 [IST]	Indian glove industry awaits implementation of Quality Control Order under WTO, TBT agreement
16:30 [IST]	GS1 General Assembly 2025 hosted by GS1 India with a vision for trusted data in healthcare, pharma

more news >>

TOP NEWS


08:00 [IST]	Delhi High Court sets aside patent office's order rejecting Taiho Pharma's application
08:00 [IST]	Pioma Chemicals sets new Global Standards with Biopol – a safer, consistent & premium alternative to benzene based Carbomers
08:00 [IST]	Healthcare industry’s global workforce mobility fast-tracked with AI-powered recruitment platforms
08:00 [IST]	Gujarat FDCA Commissioner Dr. Koshia honoured with CASMB Award for impactful leadership in public health
08:00 [IST]	Indian healthcare sector alarmed over dengue rise as climate change widens danger zone for vector borne diseases
08:00 [IST]	Pharmaceuticals exports grew 2.37 per cent in April 2025

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Cortechs.ai and ALZ-NET announce strategic collaboration to improve Alzheimer’s disease care through AI-driven imaging
17:00 [IST]	Armata Pharma reports positive data from phase 1b/2a diSArm study of intravenously administered AP-SA02 to treat S. aureus bacteremia
16:15 [IST]	Neuberg Diagnostics & Star Imaging enter joint venture to form Maharashtra’s largest integrated diagnostics network
14:30 [IST]	Pfizer enters exclusive global, ex-China licensing pact with 3SBio for development, manufacturing & commercialization of SSGJ-707
14:15 [IST]	Lupin and Honeywell team-up to develop HFO technology in inhalers
12:45 [IST]	Eris Lifesciences Q4 FY25 revenue at Rs. 705 crore, up by 28% YoY

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

Zydus Lifesciences net profit declines 1% in Q4FY25 Eris Lifesciences Q4 FY25 revenue at Rs. 705 crore, up by 28% YoY USFDA Warning Letters Recently Posted For March 2025 USFDA Warning Letters Recently Posted For February 2025 Mephenamic Acid 250mg And Dicyclomine 20mg Tab

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers